000 02606nam a22003857a 4500
008 230815s20232023 xxu||||| |||| 00| 0 eng d
022 _a2226-4787
024 _a10.3390/pharmacy11040113 [doi]
024 _apharmacy11040113 [pii]
024 _aPMC10366912 [pmc]
040 _aOvid MEDLINE(R)
099 _a37489344
245 _aEvaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD.
251 _aPharmacy : A Journal Of Pharmacy Education And Practice. 11(4), 2023 Jul 06.
252 _aPharmacy (Basel). 11(4), 2023 Jul 06.
253 _aPharmacy (Basel, Switzerland)
260 _c2023
260 _fFY2024
260 _p2023 Jul 06
265 _sepublish
265 _tPubMed-not-MEDLINE
266 _d2023-08-15
520 _aDry powder inhalers are an effective yet costly COPD medication-delivery device. Patients must possess a minimum peak inspiratory flow rate (PIFR) for inhaled medication to be properly deposited into the lungs. Hospitalized palliative-care patients with diminished lung function due to advanced COPD may not possess the minimum PIFR (30 L/min) for adequate drug delivery. This study aims to quantify PIFR values for hospitalized palliative-care patients with advanced COPD to evaluate whether these patients meet the minimum PIFR requirements. Hospitalized patients >=18 years old with a palliative-care consultation were eligible if they had a diagnosis of advanced COPD (GOLD C or D). Patients were excluded if they lacked decision-making capacity or had a positive COVID-19 test within the previous 90 days. Three PIFR values were recorded utilizing the In-CheckTM device, with the highest of the three PIFR attempts being utilized for statistical analysis. Eighteen patients were enrolled, and the mean of the highest PIFR readings was 72.5 L/min (+/-29 L/min). Post hoc analysis indicated 99.9% power when comparing the average best PIFR to the minimum PIFR (30 L/min) but only 51.4% power when compared to the optimal PIFR (60 L/min). This study found that palliative-care patients possess the minimum PIFR for DPI drug delivery.
546 _aEnglish
650 _zAutomated
651 _aMedStar Franklin Square Medical Center
656 _aAVP, Palliative Care
656 _aMedStar Health
657 _aJournal Article
700 _aCook, Heather
_bMFSMC
700 _aWalker, Kathryn A
_bMSH
790 _aBorris J, Chae S, Cook H, McPherson ML, Walker KA
856 _uhttps://dx.doi.org/10.3390/pharmacy11040113
_zhttps://dx.doi.org/10.3390/pharmacy11040113
942 _cART
_dArticle
999 _c13071
_d13071